Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs Heparin in Elderly STEMI Patients (BEST)
NCT03882775Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bivalirudin in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoints: Major adverse cardiac events at 7 days and Major bleeding at 7 days. Status: unknown.
02
Drugs
bivalirudin
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03882775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882775.